Stem Cell Therapy for Alzheimer’s

Alzheimer’s disease is a progressive neurological disorder that causes memory loss, cognitive decline, and changes in behavior. However, due to the lack of effective traditional therapies, many patients and their caretakers are searching for new treatment approaches.

There is now a new method of treating Alzheimer’s disease that is referred to as stem cell therapy for Alzheimer’s. This approach has the potential to slow down the advancement of Alzheimer’s disease and improve the quality of life. 

Let’s examine this topic from different perspectives to better understand its real implications. 

Why Use Stem Cells to Treat Alzheimer’s Disease?

Alzheimer’s disease is caused by dying brain cells that result in a loss of understanding and memory ability. The classic therapies are concentrated on treating symptoms of the disease. Stem cell research brings a new angle through the possible regenerative impacts on impaired brain parts. 

Stem cells have the distinguished capacity to turn into many different cells, including neurons. Additionally, neurotrophic factors secreted by stem cells facilitate the survival and regeneration of already existing neurons, thereby promoting brain health and potentially slowing the progression of Alzheimer’s.

Another important thing about stem cell therapy for Alzheimer’s is that it has the ability to reduce neuroinflammation. Alzheimer’s disease is characterized by inflammatory processes that worsen the condition and prolong the injury of nerve cells. Mesenchymal stem cells (MSCs) may cause an anti-inflammatory effect, helping to restore and support the brain’s normal reparative and functional activities. 

Get a free online consultation

Contact us to learn about the expected results of the treatment, its cost and duration.

Dr. Aleksandra Fetyukhina, MD

Medical Advisor, Swiss Medica doctor

Your Name Please fill out this field Phone Please fill out this field E-mail Please fill out this field

I agree to the Terms of Use, Privacy Policy and Notice Swiss Medica

What Are the Benefits of Stem Cell Therapy for Alzheimer’s? 

Formally accepted, stem cell therapy for Alzheimer’s disease has a lot of advantages, including:

1. Neuronal regeneration

MSCs can aid neuronal regeneration by releasing growth factors that promote the repair and survival of neurons. Although MSCs do not directly turn into neurons, their ability to modulate the immune response and secrete neuroprotective factors.

Neuronal stem cells have the ability to differentiate directly into neurons and other brain cells, which means that this stem cell transplant for Alzheimer’s disease may replace lost or damaged neurons and integrate into existing neural networks. This makes them a promising option for directly restoring brain function and enhancing cognitive abilities and memory. 

2. Lowering inflammation

Multipotent stem cells used in Alzheimer’s treatment provide extra benefits by helping certain immune cells, called macrophages, switch to a type that reduces inflammation in the brain. This anti-inflammatory effect can be helpful in slowing down the damage caused by Alzheimer’s disease.

3. Protecting brain cells

Stem cells release a number of neurotrophic factors to aid in the survival, growth, and maintenance of neurons, which can delay disease progression.

4. Immune modulation 

The immune response can be regulated by stem cells, thus preventing the immune system from attacking healthy brain tissue. In addition, this regulation can further minimize inflammation and lessen any damage to neurons. 

5. Overall brain health 

MSCs stimulate brain tissue repair by releasing protective factors that support cell health and reduce inflammation. This can lead to improved brain function, potentially allowing patients to enjoy a better quality of life and longer periods of independence.

Neuronal stem cells directly replace damaged or lost neurons, promoting brain repair. This regeneration of brain cells can enhance cognitive function, helping patients maintain a better quality of life and extend their independence through improved brain health.

For people who’ve not seen much progress from conventional therapies, stem cell therapy may become a hopeful way for managing Alzheimer’s disease symptoms.

What Types of Stem Cells Can Treat Alzheimer’s Disease? 

Various kinds of stem cells have been researched as potential treatments for Alzheimer’s disease. The most commonly studied include mesenchymal stem cells (MSCs) and neural stem cells (NSCs).

1. Mesenchymal stem cells (MSCs)

The antecedents of mesenchymal stem cells are small stromal cells, multipotent for differentiating into many different types. Because of their anti-inflammatory and immunomodulatory abilities, they can decrease brain inflammation caused by Alzheimer’s disease and maintain neuronal life. 

2. Neural stem cells and Alzheimer’s disease

Neural stem cells are unique stem cells found naturally in our brains that have the ability to differentiate into neurons, as well as glial cells such as astrocytes and oligodendrocytes. These can replace those that have been damaged by diseases such as Alzheimer’s; hence, the synergy of neural stem cells and Alzheimer’s disease promotes direct neural renewal in such patients.

Induced pluripotent stem cells (iPSCs) are primarily used for research purposes in the context of Alzheimer’s disease (AD), but they also hold potential for future therapeutic applications. To produce iPSCs, mature cells are reverted back to an embryonic state. They possess the power to ultimately turn into any kind of cell found within the human body system, such as neurons. iPSCs offer a personalized approach as they can be generated from the patient’s own cells, reducing the risk of immune rejection.

Every kind of stem cell has specific advantages and potential uses in Alzheimer’s disease stem cell treatment. Yet MSCs are still being used more than others because they are more available, safer, and have many beneficial effects.

Embryonic Stem Cells Treating Alzheimer’s Disease

Embryonic stem cells possess the capacity to evolve into any type of cell, giving them a lot of potential in curing various diseases, such as Alzheimer’s. 

Nonetheless, the usage of this stem cell transplant for Alzheimer’s disease in clinics has raised heated debates from different quarters since there are so many bioethical controversies surrounding it. Some of the significant concerns raised include:

1. Ethical issues 

ESCs application entails the destruction of human embryos, and this gives rise to moral dilemmas and scientific ethics. This ethical dilemma has led to strict laws that are reducing the availability of ESCs for clinical trials and studies.

2. Tumor risk

When ESCs are transplanted into patients, they are more likely to develop teratomas, another name for a particular kind of tumor. This danger is particularly serious in the case of embryonic stem cells for Alzheimer’s disease.

However, Swiss Medica does not use embryonic stem cells for Alzheimer’s disease due to ethical reasons and potential dangers; rather, we prefer adult stem cells like MSCs for medical treatment.

Stem Cell Therapy is One of the Latest Alzheimer’s Disease Treatments

Alzheimer’s disease treatment by stem cell therapy is one of the newest options in the medical world. It attempts to slow down the progression of the disease, while traditional approaches only try to control its symptoms. Furthermore, stem cell therapy for Alzheimer’s in 2024 aims to reverse cell defects.

Recently, the potential of stem cell therapy for Alzheimer’s has been shown in a variety of preclinical and clinical medical studies. Studies have shown that stem cells can develop into neurons, produce neurotrophic factors (supporting growth within the nervous system), and lower neuroinflammation, hence improving cognitive function and slowing down the progression of diseases.

Also, stem cell therapy for Alzheimer’s disease has proved effective when used in conjunction with medication therapy or regulated life practices.

Side Effects of Stem Cell Therapy for Alzheimer’s Disease

Although stem cell therapy for Alzheimer’s shows great potential, potential side effects along with the risks of this treatment must be taken into account. In general, stem cell therapy is perceived as a risk-free treatment option, particularly when MSCs are used. Nevertheless, like any other medical intervention, there are a few unwanted effects:

• Temporary inflammation;
• Swelling at the injection site;
• Minor risk of infection;
• Immune response to the introduced cells. This risk is minimized by using the patient’s own cells.
• Headaches and fever;
• Tumor formation with embryonic stem cells.

Swiss Medica ensures the highest degree of safety by conducting a detailed examination of donor cells for infections and genetic alterations. We also ensure sterility during cell handling and administration. The rigorous nature of this process helps reduce the chances for side effects related to Alzheimer’s patients who use stem cell therapy. 

Best Stem Cell Clinic for Alzheimer’s Treatment with Stem Cells

Choosing the right clinic for Alzheimer’s disease stem cell treatment is crucial for achieving the best possible outcomes.

The clinic, equipped with cutting-edge technology, sterile environments, personalized treatment plans, and an experienced team specializing in regenerative medicine and comprehensive care, is considered the best.

Swiss Medica stands out as a leading clinic for Alzheimer’s disease stem cell treatment, offering a combination of expertise, advanced technology, and personalized care.  Choosing Swiss Medica ensures that patients receive the best possible care, maximizing the benefits of stem cells treating Alzheimer’s disease.

Why Choose Swiss Medica for Stem Cell Therapy for Alzheimer’s?

Swiss Medica is a premier choice for Alzheimer’s disease treatment by stem cell therapy due to several key factors:

• Extensive expertise in regenerative medicine;
• Proven track record with numerous positive reviews from our patients;
• Ethical and safe practices, including the use of adult mesenchymal stem cells;
• Comprehensive support to patients, from travel assistance to pre- and after care;
• Patient-centered approach with personalized treatment plans;
• In-house laboratory providing live stem cells;
• Rigorous quality control at every stage of the treatment, ensuring advanced safety.

These factors make Swiss Medica a leading choice for patients seeking innovative and effective stem cell therapy for Alzheimer’s disease.

Real Patient Stories

The Swiss Medica clinic has seen numerous benefits of stem cell research for Alzheimer’s patients. One of the patients, Randi from Norway, has been getting her stem cell therapy treatment for her condition. The therapy is expected to have a positive result, stopping the progression of the disease. 

Also, the disease has not developed further, and Randi can go back to living her normal life. She’s able to drive her car and go on about her daily activities, and there’s nothing more she wants.

‘They have stopped the progression of the disease. And there has been no development in the four months since we were last here.’

You can watch the full review on our YouTube channel.

The Success Rate of Stem Cell Therapy for Alzheimer’s Disease at Swiss Medica

We have observed encouraging results from the usage of stem cell therapy for Alzheimer’s at Swiss Medica. It is important to note that actual results can vary significantly in terms of outcomes in every case. However, most of our patients have noted an increased level of memory awareness as well as better cognitive functions altogether. Some other benefits are

1. Enhanced memory 

2. Decreased symptoms such as confusion, agitation, and behavioral changes 

3. Reduced disease progression

4. Improved ability to perform everyday activities

Can Stem Cells Cure Alzheimer’s Disease?

It is important to note that at the moment, there are no stem cells curing for Alzheimer’s, including mesenchymal stem cells for Alzheimer’s disease.

The purpose of therapies with mesenchymal stem cells for Alzheimer’s disease is to repair damaged brain cells, support their general health, reduce neuroinflammation, and regenerate nerve endings. While such changes may result in a better quality of life, they might not go beyond repair.

In Swiss Medica, we prioritize more realistic anticipation and provide substantial comprehension of what can be accomplished through stem cells in treating Alzheimer’s disease. Our aim is to create both optimism and better-grounded lives through innovative intervention methods for patients suffering from Alzheimer’s disease. 

Stem Cell Alzheimer’s Treatment Cost

The cost of stem cell therapy for Alzheimer’s patients undergoing a stem cell treatment differs depending on factors like age, stage of the disease, number of treatments required, as well as the specific protocols involved. At Swiss Medica, the cost typically ranges from €7,000 to €25,000.

Stem Cell Research for Alzheimer’s

Research on stem cells curing Alzheimer’s disease is changing quickly as scientists continue to investigate new ways in which stem cells might help people who have this disorder. Researchers are investigating different factors about stem cells used to treat Alzheimer’s, types of cells themselves (such as which ones work best), ways cells are introduced into the body, and the ways stem cells trigger positive responses in patients.

Studies are being undertaken to establish if stem cells may shield the already existing neurons and help in the repair of impaired brain tissues, reversing some of the effects of Alzheimer’s disease. 

Also, there are inquiries as to whether stem cells could alter immunity to decrease neuroinflammation while avoiding further neuronal destruction. Ongoing research and clinical trials show that treatment approaches are available through stem cells used to treat Alzheimer’s, which can effectively manage the disease.

Alzheimer’s Disease Stem Cell Treatment Clinical Trials

Alzheimer’s disease treatment by stem cell therapy depends heavily on clinical trials to advance stem cell therapy. They provide important data about treatment safety and effectiveness.

1. These stem cell therapies in Alzheimer’s clinical trials are meant to ensure the safety of stem cell therapy, discover the right dosages, and potential side effects that can be encountered prior to taking it further.

2. Based on phase I safety information, subsequent trials establish the effectiveness of the treatment. They try to determine whether or not treatment affects cognitive abilities, leads to more severe stages of an illness, or brings about general improvement in a patient’s life.

3. The major purpose of the large-scale stem cell therapy in Alzheimer’s clinical trials is to prove the efficiency of this therapy while evaluating its long-term effects and comparing it with the established ones.

At the moment, there are a lot of clinical experiments exploring various aspects of stem cell therapy for Alzheimer’s, such as different stem cell types, novel delivery methods, and combination therapies.

What’s the Outlook for Stem Cell Therapy for Alzheimer’s?

There is an optimistic outlook regarding the use of stem cells for managing Alzheimer’s disease. Current research indicates that stem cells can boost cognitive functions, lessen neuroinflammation, and support neuronal health. The efficacy and safety of stem cell therapy is foreseen to increase as researchers constantly improve the techniques and protocols to better suit a broader range of patients. 

Again, using cutting-edge technologies such as gene editing and personalized medicine, stem cell therapy for Alzheimer’s in 2024 can be customized to individual patients’ needs.

These improvements could result in treating diseases in more specific ways, with concern for the patient’s unique disease characteristics. Despite challenges like delivering stem cells into the body and ensuring long-term patient safety, progress is being made, and there are encouraging signs of success.

Frequently Asked Questions about Alzheimer’s Disease

Contact us

Contact our medical advisor to receive a customised stem-cell based anti-ageing programme.

Dr. Aleksandra Fetyukhina, MD

Medical Advisor, Swiss Medica doctor

Your Name Please fill out this field Phone Please fill out this field E-mail Please fill out this field

I agree to the Terms of Use, Privacy Policy and Notice Swiss Medica

Natalia Semeshina Author

Dr. Aleksandra Fetyukhina, MD Reviewer

Medical Advisor, Swiss Medica doctor